$0.7800
-0.04-4.42%
At close: -
$0.8180
0.044.87%
After Hours: Feb 20, 7:32 PM EDT
Comments
Loading...
Latest news for CytomX Therapeutics (NASDAQ:CTMX) Stock
CytomX Therapeutics Stock (NASDAQ: CTMX)
Categories: All
Tuesday, January 07, 2025
Monday, January 06, 2025
Monday, November 11, 2024
Friday, November 08, 2024
Thursday, November 07, 2024
Friday, September 13, 2024
Monday, September 09, 2024
Thursday, August 22, 2024
Friday, August 09, 2024
Thursday, August 08, 2024
Thursday, June 27, 2024
Monday, June 17, 2024
Wednesday, June 05, 2024
Tuesday, May 28, 2024
Thursday, May 09, 2024
- Analysts' Varied Perspectives On CytomX's CX-904 Cancer Study: Safety Profile But Caution in Pancreatic Cancer
- Gold Moves Higher; Roblox Issues Weak Outlook
- Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Dow Jumps Over 150 Points; US Foods Posts Upbeat Earnings
- BMO Capital Maintains Market Perform on Cytom...
- HC Wainwright & Co. Reiterates Neutral on Cyt...
- Wedbush Upgrades CytomX Therapeutics to Outpe...
- Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- CytomX Therapeutics shares are trading lower,...
Wednesday, May 08, 2024
Tuesday, May 07, 2024
Monday, May 06, 2024
Thursday, May 02, 2024
Wednesday, May 01, 2024
- Dow Jumps 200 Points Following Fed Decision; Pfizer Earnings Top Estimates
- Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- Crude Oil Down 3%; ISM Manufacturing PMI Falls In April
- BMO Capital Reiterates Market Perform on Cyto...
- What's Going On With CytomX Stock?
- CytomX Therapeutics shares are trading higher...
- CytomX Therapeutics Shares Resume Trade After...
- CORRECTION: CytomX Therapeutics Ticker Is CTM...
- US Stocks Mixed; Amazon Posts Upbeat Earnings
- CytomX Therapeutics To Provide An Initial CX-...